Asian Pain Academy

Introduction Tramadol has long been regarded as a “safer opioid,” often prescribed for the management of chronic non-cancer pain. Its dual mechanism — weak μ-opioid receptor agonism and inhibition of serotonin and norepinephrine reuptake — made it a preferred choice for clinicians seeking an alternative to stronger opioids. However, a new systematic review and meta-analysis  published in BMJ Evidence-Based Medicine  (2025) has raised Important questions about tramadol’s true

Introduction 👉 Could one of our most trusted pain medicines be quietly raising the risk of heart failure in elderly patients?...

Introduction The U.S. Food and Drug Administration ( FDA ) has approved Tonmya  (cyclobenzaprine HCl sublingual tablets) on August 15,...

Ketamine infusion for chronic pain – Cochrane Review 2025 findings Introduction The idea of using ketamine for chronic pain  has...

Published by: Asian Pain Academy – Pain Management Training Academy Introduction: Redefining Migraine Management, Rimegepant for Migraine...

Uncover the evolution of gastric acid suppression beyond proton pump inhibitors at Asian Pain Academy. Explore the latest advancements in...

Learn how Carbamazepine can effectively manage chronic pain through the Carbamazepine Chronic Pain Management Fellowship at Asian Pain...

Learn how to effectively use Gabapentin in pain management with our comprehensive online course. Gain valuable knowledge. Indications -...